© 2013 - Maastricht UMC Holding
IP Randwyck specialises in the exchange of knowledge in the field of life sciences and biomedical technologies. Its goal is valorisation – the offering of academic knowledge from university hospital Maastricht to the business world and to society in general.
The company was incorporated in 2003. In 2006 the shares in IP Randwyck were transferred to Maastricht UMC+ by the foundation Stichting Sint Annadal. All rights to the inventions and applications created by Maastricht UMC+ were transferred to IP Randwyck. BioMedbooster acquired the beneficial ownership of these rights and inventions under an exclusive licence. However, legal ownership remains with IP Randwyck.
Postbus 5800, 6202 AZ Maastricht, Netherlands
P. Debylaan 25, 6229 HX Maastricht
T 043 – 387 2044